Top Markets
Coin of the day
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVB
Rangering i aksjer #99999
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the... Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
Aksjekurs
$0.09933121
Markedsverdi
$29.15K
Endring (1 dag)
0.57%
Endring (1 år)
449.49%
Land
IE
Handel Ovoca Bio plc (OVB)

Kategori

Inntekter for Ovoca Bio plc (OVB)
Inntekter i Jun 2024 TTM: $-5.54M
Ifølge Ovoca Bio plc sine nyeste økonomiske rapporter er selskapets nåværende resultat $-5.54M. I 2023 hadde selskapet et resultat på $-5.64M, en økning sammenlignet med resultatet i 2022, som var $-6.02M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Ovoca Bio plc fra 2001 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $-5.54M 177,402.36%
2024 $-3.12K -99.94%
2023 $-5.64M -6.27%
2022 $-6.02M 0.89%
2021 $-5.97M 111.35%
2020 $-2.82M 32.29%
2019 $-2.13M -6.96%
2018 $-2.29M 401.73%
2017 $-457.16K -54.69%
2016 $-1.01M -58.18%
2015 $-2.41M -69.99%
2014 $-8.04M -60.54%
2013 $-20.37M 592.33%
2012 $-2.94M -153.33%
2011 $5.52M 340.98%
2010 $1.25M -87.44%
2009 $9.96M -683.08%
2008 $-1.71M 36.71%
2007 $-1.25M -81.83%
2006 $-6.88M 549.04%
2005 $-1.06M 285.00%
2004 $-275.29K 10.93%
2003 $-248.17K 96.02%
2002 $-126.60K -32.76%
2001 $-188.29K 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$20.46B -369,289.88%
DK
$4.64B -83,895.77%
US
$5.23B -94,498.38%
US
$2.14B -38,678.95%
BE
$1.45B -26,287.63%
NL